Nisa Investment Advisors, LLC Cara Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$1.67 - $3.33 $3,906 - $7,788	-2,339 Reduced 95.08%	121 $0
Q2 2023 Aug 11, 2023	BUY	$2.83 - $4.94 $5,263 - $9,188	1,860 Added 310.0%	2,460 $6,000
Q1 2023 May 02, 2023	SELL	$4.89 - $12.27 $288 - $723	-59 Reduced 8.95%	600 $3,000
Q3 2022 Nov 07, 2022	BUY	$8.24 - $12.56 $486 - $741	59 Added 9.83%	659 $6,000
Q1 2022 Apr 29, 2022	SELL	$9.94 - $12.65 $114,618 - $145,867	-11,531 Reduced 95.05%	600 $7,000
Q4 2021 Feb 03, 2022	BUY	$11.99 - $18.14 $17,781 - $26,901	1,483 Added 13.93%	12,131 $140,000
Q3 2021 Oct 18, 2021	BUY	$11.55 - $16.06 $113,166 - $157,355	9,798 Added 1152.71%	10,648 $165,000
Q4 2020 Jan 25, 2021	BUY	$12.72 - $16.16 $4,452 - $5,656	350 Added 70.0%	850 $13,000
Q1 2019 Apr 17, 2019	SELL	$14.41 - $19.64 $2,161 - $2,946	-150 Reduced 23.08%	500 $10,000
Q1 2018 Apr 10, 2018	SELL	$11.77 - $16.08 $1,765 - $2,411	-150 Reduced 18.75%	650 $8,000
Q4 2017 Jan 12, 2018	BUY	$11.86 - $14.08 $3,558 - $4,224	300 Added 60.0%	800 $10,000
Q3 2017 Oct 13, 2017	BUY	$12.6 - $16.34 $6,300 - $8,170	500	500 $7,000

16.5M

55K

500

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.1M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.